A critical breakthrough in cancer investigation is occurring with the use of mini-antibodies to re-engage dysfunctional p53. This crucial cancer suppressor protein is frequently disabled in several forms of tumors, https://worldlistpro.com/story24052116/nanobodies-reactivate-p53-new-potential-hope-for-tumor-therapy